Seasonal and Pandemic Influenza. An Overview with Pediatric Focus

Advances in Pediatrics

Volumn 59, Issue 1, 2012, Pages 75-93

  Carr, Silvana ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Antiviral; Children; Influenza; Vaccination

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

CHEMISTRY; CHILD; EPIDEMIC; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; METHODOLOGY; PEDIATRICS; PHYSIOLOGY; PRESCHOOL CHILD; REVIEW;

ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PEDIATRICS;

EID: 84863841620     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yapd.2012.04.016     Document Type: Review

References (77)

1. Glezen W.P., Couch R.B., MacLean R.A., et al. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med 1978, 298:587-592.
2. American Academy of Pediatrics Committee on Infectious Diseases Recommendations for prevention and control of influenza in children, 2011-2012. Pediatrics 2011, 128:813-825.
3. Jain S., Kamimoto L., Bramley A.M., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944.
4. Whitley R.J., Hayden F.G., Reisinger K.S., et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001, 20:127.
5. Kaiser L., Wat C., Mills T., et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003, 163:1667.
6. Wright P.F., Webster R.G. Orthomyxoviruses. Fields virology 2001, vol. 1:1533-1579. Lippincott, Philadelphia. 4th edition.
7. Samji T. Influenza A: understanding the viral life cycle. Yale J Biol Med 2009, 82:153.
8. La Gruta N.L., Kedzierska K., Stambas J., et al. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007, 85:85-92.
9. Clements M., O'Donnell S., Levine M., et al. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect Immun 1983, 40:1044.
10. Clements M., Betts R., Tierney E., et al. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 1986, 24:157.
11. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990, 8:737-787.
12. Gerhard W. The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol 2001, 260:171.
13. Valkenburg S.A., Rutigliano J.A., Ellebedy A.H., et al. Immunity to seasonal and pandemic influenza A viruses. Microbes Infect 2011, 13:489-501.
14. Webster R.G., Bean W.J. Evolution and ecology of influenza viruses: interspecies transmission. Textbook of influenza 1998, 109-119. Blackwell Science, Oxford (United Kingdom). K.G. Nicholson, R.G. Webster, A. Hay (Eds.).
15. Garden R.J., Davis C.T., Russell C.A., et al. Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009, 325:197.
16. Malik Peiris J., Poon L.L., Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009, 45:169-173.
17. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista E., Chotpitayasunondh T. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362:1708-1719.
18. Yorke J.A., Nathanson N., Pianigiani G., et al. Seasonality and the requirements for perpetuation and eradication of viruses in populations. Am J Epidemiol 1979, 109:103.
19. Simonsen L., Clarke M., Williamson G., et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997, 87:1944.
20. Hall C.B. The spread of influenza and other respiratory viruses: complexities and conjectures. Clin Infect Dis 2007, 45:353.
21. Fiore A.E., Fry A., Shay D., et al. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60:1.
22. Wong B.C., Lee N., Li Y., et al. Possible role of aerosol transmission in a hospital outbreak of influenza. Clin Infect Dis 2010, 51:1176.
23. Cox N.J., Subbarao K. Influenza. Lancet 1999, 354:1277-1282.
24. Carrat F., Vergu E., Ferguson N.M., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167:775.
25. Glezen W.P., Paredes A., Taber L.H. Influenza in children. JAMA 1980, 243:1345.
26. Neuzil K.M., Mellen B.G., Wright P.F., et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000, 342:225-231.
27. Glezen W.P., Decker M., Joseph S.W., et al. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis 1987, 155:1119.
28. Izurieta H.S., Thompson W.W., Kramarz P., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000, 342:232-239.
29. Dunn F.L., Carey D.E., Cohen A., et al. Epidemiologic studies of Asian influenza in a Louisiana parish. Am J Epidemiol 1959, 70:351-371.
30. Glezen W.P. Herd protection against influenza. J Clin Virol 2006, 37:237-243.
31. Harper S.A., Bradley J.S., Englund J.A., et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1003.
32. Fiore A.E., Uyeki T.M., Broder K., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59:1.
33. Erhart L.M., Rangel M.C., Lu P.J., et al. Prevalence and characteristics of children at increased risk for complications from influenza, United States, 2000. J Pediatr 2004, 144:191-195.
34. Louria D.B., Blumenfeld H.L., Ellis J.T., et al. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 1959, 38:213.
35. Centers for Disease Control and Prevention Influenza activity-United States and worldwide, 2007-08 season. MMWR Morb Mortal Wkly Rep 2008, 57:692-697.
36. Muñoz F.M. The impact of influenza in children. Semin Pediatr Infect Dis 2002, 13(2):72-78.
37. Dagan R., Hall C.B. Influenza A virus infection imitating bacterial sepsis in early infancy. Pediatr Infect Dis 1984, 3:218.
38. Nicholson K.G. Clinical features of influenza. Semin Respir Infect 1992, 7:26-37.
39. Peltola V., Ziegler T., Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis 2003, 36:299.
40. Wright P.F., Bryant J.D., Karzon D.T. Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis 1980, 141:430.
41. Glezen W.P., Taber L.H., Frank A.L., et al. Influenza virus infections in infants. Pediatr Infect Dis J 1997, 16:1065-1068.
42. Edwards K.M., Dundon M.C., Altemeier W.A. Bacterial tracheitis as a complication of viral croup. Pediatr Infect Dis 1983, 2:390.
43. Troendle J.F., Demmler G.J., Glezen W.P., et al. Fatal influenza B virus pneumonia in pediatric patients. Pediatr Infect Dis J 1992, 11:117.
44. Heikkinen T., Thint M., Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999, 340:260-264.
45. Chiu S.S., Tse C.Y., Lau Y.L., et al. Influenza A infection is an important cause of febrile seizures. Pediatrics 2001, 108:e63.
46. Hawkes M., Schuh S., Ipp M., et al. Natural history of pandemic H1N1 2009 influenza infection in healthy pediatric outpatients. Acad Pediatr 2011, 11:66-74.
47. Morens D.M., Fauci A.S. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007, 195:1018.
48. Bonner A.B., Monroe K.W., Talley L.I., et al. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003, 112:363.
49. Barenfanger J., Drake C., Leon N., et al. Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study. J Clin Microbiol 2000, 38:2824.
50. Jennings L.C., Skopnik H., Burckhardt I., et al. Effect of rapid influenza testing on the clinical management of paediatric influenza. Influenza Other Respi Viruses 2009, 3:91-98.
51. Chung E.Y., Chiang V.W. Influenza vaccination, diagnosis, and treatment in children. Pediatr Emerg Care 2011, 27:760.
52. Leonardi G.P., Mitrache I., Pigal A., et al. Public hospital-based laboratory experience during an outbreak of pandemic influenza A (H1N1) virus infections. J Clin Microbiol 2010, 48:1189-1194.
53. Balish A., Warnes C., Wu K., et al. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus-United States, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:826-829.
54. Uyeki T. Diagnostic testing for 2009 pandemic influenza A (H1N1) virus infection in hospitalized patients. N Engl J Med 2009, 361:e114.
55. Landry M.L. Diagnostic tests for influenza infection. Curr Opin Pediatr 2011, 23:91-97.
56. Bhat N., Wright J.G., Broder K.R., et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005, 353:2559-2567.
57. Jordan W., Denny F., Badger G.F., et al. A study of illness in a group of Cleveland families. XVII. The occurrence of Asian influenza. Am J Hyg 1958, 68:190.
58. Glezen W.P. Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. Vaccine 2000, 19(Suppl 1):S56-S58.
59. Schwarzmann S.W., Adler J.L., Sullivan R.J., et al. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969: experience in a city-county hospital. Arch Intern Med 1971, 127:1037.
60. Agyeman P., Duppenthaler A., Heininger U., et al. Influenza-associated myositis in children. Infection 2004, 32:199-203.
61. DiBona F.J., Morens D.M. Rhabdomyolysis associated with influenza A: report of a case with unusual fluid and electrolyte abnormalities. J Pediatr 1977, 91:943-945.
62. Craver R.D., Sorrells K., Gohd R. Myocarditis with influenza B infection. Pediatr Infect Dis J 1997, 16:629.
63. Stuart-Harris C. Influenza and its complications. I. Br Med J 1966, 1:149.
64. Porter J., Robinson P., Glasgow J., et al. Trends in the incidence of Reye's syndrome and the use of aspirin. Arch Dis Child 1990, 65:826.
65. Widelock D., Csizmas L., Klein S. Influenza, pregnancy, and fetal outcome. Public Health Rep 1963, 78:1.
66. Moscona A. Medical management of influenza infection. Annu Rev Med 2008, 59:397-413.
67. Li J.T., Rank M.A., Squillace D.L., et al. Ovalbumin content of influenza vaccines. J Allergy Clin Immunol 2010, 125:1412.
68. Sugaya N., Mitamura K., Yamazaki M., et al. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 2007, 44:197.
69. Jackson H.C., Roberts N., Wang Z.M., et al. Management of influenza: use of new antivirals and resistance in perspective. Clin Drug Investig 2000, 20:447-454.
70. Oo C., Barrett J., Hill G., et al. Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children. Pediatr Drugs 2001, 3:229-236.
71. Toovey S., Rayner C., Prinssen E., et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. Drug Saf 2008, 31:1097-1114.
72. Acosta E.P., Jester P., Gal P., et al. Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis 2010, 202:563.
73. Englund J.A., Walter E.B., Fairchok M.P., et al. A comparison of 2 influenza vaccine schedules in 6-to 23-month-old children. Pediatrics 2005, 115:1039.
74. Hayden F.G., Belshe R., Villanueva C., et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004, 189:440.
75. Welliver R., Monto A.S., Carewicz O., et al. Effectiveness of oseltamivir in preventing influenza in household contacts. JAMA 2001, 285:748.
76. Hayden F.G., Gubareva L.V., Monto A.S., et al. Inhaled zanamivir for the prevention of influenza in families. N Engl J Med 2000, 343:1282-1289.
77. Monto A.S., Pichichero M.E., Blanckenberg S.J., et al. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. J Infect Dis 2002, 186:1582.